Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy
- Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microe...
United States Raj Malik Therapeutics Inc Investor Relations Corporate Communications Exchange Commission Research Triangle Park
Source: sina.com.hk